Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Sell
5,297
-184
-3% -$63K 0.14% 59
2026
Q1
$1.93M Sell
5,481
-207
-4% -$73.8K 0.15% 55
2025
Q4
$1.86M Sell
5,688
-135
-2% -$42.8K 0.15% 61
2025
Q3
$1.64M Buy
5,823
+70
+1% +$20.3K 0.14% 73
2025
Q2
$1.61M Buy
5,753
+44
+0.8% +$12.5K 0.14% 74
2025
Q1
$1.78M Sell
5,709
-569
-9% -$168K 0.17% 65
2024
Q4
$1.64M Buy
6,278
+66
+1% +$19.6K 0.15% 78
2024
Q3
$2M Buy
6,212
+71
+1% +$23.2K 0.19% 63
2024
Q2
$1.92M Buy
6,141
+22
+0.4% +$6.46K 0.19% 66
2024
Q1
$1.74M Sell
6,119
-299
-5% -$87.5K 0.18% 75
2023
Q4
$1.85M Sell
6,418
-85
-1% -$23.2K 0.2% 73
2023
Q3
$1.75M Buy
6,503
+51
+0.8% +$12.7K 0.21% 67
2023
Q2
$1.43M Buy
6,452
+147
+2% +$34.1K 0.16% 82
2023
Q1
$1.52M Sell
6,305
-369
-6% -$90.6K 0.18% 81
2022
Q4
$1.75M Sell
6,674
-1,730
-21% -$464K 0.21% 63
2022
Q3
$1.89M Buy
8,404
+1,207
+17% +$293K 0.22% 64
2022
Q2
$1.75M Buy
+7,197
New +$1.76M 0.19% 72
2022
Q1
Sell
-6,058
Closed -$1.36M 187
2021
Q4
$1.36M Buy
6,058
+927
+18% +$196K 0.13% 100
2021
Q3
$1.09M Buy
5,131
+1,494
+41% +$344K 0.11% 107
2021
Q2
$887K Buy
3,637
+92
+3% +$22.6K 0.1% 107
2021
Q1
$882K Buy
3,545
+264
+8% +$63K 0.11% 104
2020
Q4
$754K Sell
3,281
-241
-7% -$55.6K 0.1% 107
2020
Q3
$895K Buy
3,522
+346
+11% +$85.7K 0.14% 92
2020
Q2
$749K Sell
3,176
-132
-4% -$30.1K 0.12% 99
2020
Q1
$670K Sell
3,308
-53
-2% -$11.6K 0.12% 95
2019
Q4
$810K Buy
3,361
+42
+1% +$9.26K 0.13% 100
2019
Q3
$642K Buy
3,319
+607
+22% +$117K 0.11% 107
2019
Q2
$499K Buy
2,712
+30
+1% +$5.37K 0.09% 113
2019
Q1
$510K Buy
2,682
+55
+2% +$10.5K 0.1% 115
2018
Q4
$511K Sell
2,627
-180
-6% -$35.1K 0.11% 114
2018
Q3
$582K Buy
2,807
+92
+3% +$18.1K 0.11% 116
2018
Q2
$501K Sell
2,715
-270
-9% -$47.8K 0.1% 119
2018
Q1
$509K Sell
2,985
-52
-2% -$9.54K 0.1% 114
2017
Q4
$528K Buy
3,037
+136
+5% +$24.1K 0.1% 113
2017
Q3
$540K Buy
+2,901
New +$514K 0.11% 106
2017
Q2
Sell
-2,500
Closed -$410K 140
2017
Q1
$410K Buy
2,500
+59
+2% +$9.8K 0.09% 107
2016
Q4
$357K Sell
2,441
-20
-0.8% -$3.01K 0.08% 112
2016
Q3
$411K Buy
2,461
+200
+9% +$33.8K 0.1% 102
2016
Q2
$344K Sell
2,261
-111
-5% -$17.3K 0.08% 113
2016
Q1
$356K Buy
2,372
+83
+4% +$12.3K 0.09% 108
2015
Q4
$372K Buy
2,289
+12
+0.5% +$1.89K 0.09% 104
2015
Q3
$315K Buy
2,277
+87
+4% +$13.7K 0.08% 113
2015
Q2
$336K Sell
2,190
-350
-14% -$56.1K 0.08% 119
2015
Q1
$406K Buy
2,540
+367
+17% +$57.8K 0.1% 111
2014
Q4
$346K Sell
2,173
-9
-0.4% -$1.4K 0.09% 118
2014
Q3
$306K Buy
2,182
+158
+8% +$20.6K 0.08% 123
2014
Q2
$240K Buy
+2,024
New +$234K 0.06% 135
2014
Q1
Sell
-2,014
Closed -$230K 120
2013
Q4
$230K Buy
2,014
+30
+2% +$3.41K 0.06% 137
2013
Q3
$222K Buy
+1,984
New +$215K 0.07% 123

Other funds holding AMGN

Bangor Savings Bank's AMGN Position: Q2 2026 in Review

Bangor Savings Bank reduced its Amgen (AMGN) stake by 3.4% in Q2 2026, selling an estimated $63K and leaving 5,297 shares worth $1.92M. The position accounts for 0.14% of the portfolio, ranked #59.

Bangor Savings Bank first reported a position in AMGN in Q3 2013 and has held it in 49 quarters since. The position peaked at $2M in Q3 2024. 532 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bangor Savings Bank held 5,297 shares of Amgen worth $1.92M as of Q2 2026.
  • Bangor Savings Bank sold 184 Amgen shares in Q2 2026, an estimated $63K.
  • Amgen made up 0.14% of Bangor Savings Bank's portfolio in Q2 2026, its #59 holding.
  • Bangor Savings Bank first reported a position in Amgen in Q3 2013 and has held it in 49 quarters since.
  • Bangor Savings Bank's Amgen position peaked at $2M in Q3 2024.
  • 532 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.